Dominari Holdings Correlations
DOMH Stock | 1.92 0.01 0.52% |
The current 90-days correlation between Dominari Holdings and Neoleukin Therapeutics is 0.01 (i.e., Significant diversification). The correlation of Dominari Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Dominari Holdings Correlation With Market
Average diversification
The correlation between Dominari Holdings and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Dominari Holdings and DJI in the same portfolio, assuming nothing else is changed.
Dominari |
Moving together with Dominari Stock
Moving against Dominari Stock
0.87 | RDY | Dr Reddys Laboratories | PairCorr |
0.54 | PRLD | Prelude Therapeutics | PairCorr |
0.53 | RGC | Regencell Bioscience | PairCorr |
0.48 | NBIX | Neurocrine Biosciences | PairCorr |
0.38 | MOLN | Molecular Partners Downward Rally | PairCorr |
0.74 | EUDA | EUDA Health Holdings | PairCorr |
0.55 | SUPN | Supernus Pharmaceuticals | PairCorr |
0.39 | HCTI | Healthcare Triangle | PairCorr |
0.38 | ABBV | AbbVie Inc | PairCorr |
0.31 | BDTX | Black Diamond Therap | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Dominari Stock performing well and Dominari Holdings Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Dominari Holdings' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CTMX | 2.63 | (0.33) | 0.00 | (0.08) | 0.00 | 5.63 | 17.21 | |||
TIL | 8.43 | 2.84 | 0.52 | 0.81 | 4.64 | 31.13 | 105.83 | |||
NLTX | 2.25 | (0.23) | 0.00 | (0.40) | 0.00 | 4.05 | 27.84 | |||
SPRO | 1.93 | (0.11) | 0.00 | (0.01) | 0.00 | 3.79 | 12.84 | |||
ASMB | 2.74 | 0.24 | 0.06 | 0.28 | 3.96 | 6.02 | 30.39 | |||
ACHL | 2.36 | 0.27 | 0.14 | 0.27 | 1.84 | 3.75 | 38.16 | |||
NXTC | 2.22 | (0.34) | 0.00 | (0.15) | 0.00 | 4.49 | 12.96 | |||
SNTI | 4.37 | (0.69) | 0.00 | (0.12) | 0.00 | 10.15 | 45.90 | |||
HILS | 5.56 | (0.45) | 0.00 | 0.48 | 0.00 | 8.33 | 113.15 | |||
SABS | 4.17 | (0.13) | (0.02) | 0.00 | 4.59 | 11.50 | 35.23 |
Dominari Holdings Corporate Management
Matthew McCullough | General Counsel | Profile | |
Jaime Mercado | Chief Officer | Profile | |
Christopher Devall | Chief Officer | Profile | |
George CPA | Chief Officer | Profile |